|  Help  |  About  |  Contact Us

Publication : Human fetal cerebellar cell atlas informs medulloblastoma origin and oncogenesis.

First Author  Luo Z Year  2022
Journal  Nature Volume  612
Issue  7941 Pages  787-794
PubMed ID  36450980 Mgi Jnum  J:340389
Mgi Id  MGI:7525491 Doi  10.1038/s41586-022-05487-2
Citation  Luo Z, et al. (2022) Human fetal cerebellar cell atlas informs medulloblastoma origin and oncogenesis. Nature 612(7941):787-794
abstractText  Medulloblastoma (MB) is the most common malignant childhood brain tumour(1,2), yet the origin of the most aggressive subgroup-3 form remains elusive, impeding development of effective targeted treatments. Previous analyses of mouse cerebella(3-5) have not fully defined the compositional heterogeneity of MBs. Here we undertook single-cell profiling of freshly isolated human fetal cerebella to establish a reference map delineating hierarchical cellular states in MBs. We identified a unique transitional cerebellar progenitor connecting neural stem cells to neuronal lineages in developing fetal cerebella. Intersectional analysis revealed that the transitional progenitors were enriched in aggressive MB subgroups, including group 3 and metastatic tumours. Single-cell multi-omics revealed underlying regulatory networks in the transitional progenitor populations, including transcriptional determinants HNRNPH1 and SOX11, which are correlated with clinical prognosis in group 3 MBs. Genomic and Hi-C profiling identified de novo long-range chromatin loops juxtaposing HNRNPH1/SOX11-targeted super-enhancers to cis-regulatory elements of MYC, an oncogenic driver for group 3 MBs. Targeting the transitional progenitor regulators inhibited MYC expression and MYC-driven group 3 MB growth. Our integrated single-cell atlases of human fetal cerebella and MBs show potential cell populations predisposed to transformation and regulatory circuitries underlying tumour cell states and oncogenesis, highlighting hitherto unrecognized transitional progenitor intermediates predictive of disease prognosis and potential therapeutic vulnerabilities.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

2 Bio Entities

Trail: Publication

0 Expression